FOXO Technologies Inc. (FOXO) Fair Value 2026

FOXO · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.9 /10

32 fundamental signals · 0 models active

Value Trap Risk

WARN (53/100)

Quick Summary — As of 2026-08-27, FOXO Technologies Inc. (FOXO) trades at $0.09. QOC: 3.9/10. Value Trap Risk: 53/100 (WARN). 0/13 models active.

Key Facts

Ticker
FOXO
Price
$0.09
Quality Score
3.9/10
Value Trap Risk
53/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 53 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give FOXO?

0 Intrinsic Value Models vs. Current Price ($0.09)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is FOXO Technologies Inc. (FOXO) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, FOXO Technologies Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About FOXO?

0 of 13 models are currently active for FOXO. See which stocks rank higher →

How Does FOXO Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, FOXO ranks #55 by Quality of Company score. CirclFi's QOC score of 3.9/10 evaluates 32 fundamental signals. A score of 3.9 signals below-average fundamentals.

See all Most Undervalued Medical Care Facilities Stocks →

FOXO Technologies Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is FOXO a Value Trap?

CirclFi's Value Trap algorithm assigns FOXO a score of 53/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for FOXO Technologies Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, FOXO Technologies Inc. earns a quality score of 3.9/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every FOXO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy FOXO Technologies Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

HLYKHealthLynked Corp.QOC 4.1PARKPark Dental Partners, Inc.QOC 3.9CMPSCOMPASS Pathways plcQOC 4.5GMRSGMR Solutions Inc.QOC 3.8PIIIP3 Health Partners Inc.QOC 4.7FCHSFirst Choice Healthcare Solutions, Inc.QOC 3.6CHEChemed CorporationQOC 8.2ASTHAstrana Health, Inc.QOC 7.1GBCSSelectis Health, Inc.QOC 5.9ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: HLYK · PARK · CMPS · GMRS · PIII · FCHS · CHE · ASTH · GBCS · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to FOXO?

7 companies across all industries closest to FOXO’s Quality of Company score of 3.9/10.

ESSIEco Science Solutions, Inc.QOC 3.9DWTXDogwood Therapeutics, Inc.QOC 3.9OLOXOlenox Industries Inc.QOC 3.9MBRXMoleculin Biotech, Inc.QOC 3.9WHKWhiteHawk Minerals Corp.QOC 3.9DFDVDeFi Development Corp.QOC 3.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: ESSI · DWTX · OLOX · MBRX · WHK · DFDV · NVDA

Where Does FOXO Sit in CirclFi's Medical Care Facilities Rankings?

FOXO is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About FOXO Technologies Inc.’s Valuation?

What is FOXO Technologies Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for FOXO Technologies Inc. (FOXO). The Quality of Company score is 3.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is FOXO overvalued or undervalued right now?

At $0.09, 0 of 0 active models suggest FOXO may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits FOXO Technologies Inc.'s business model in Medical Care Facilities.

What does a Quality of Company score of 3.9 mean for FOXO?

FOXO Technologies Inc.'s QOC of 3.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on FOXO?

CirclFi analyzes FOXO with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is FOXO a value trap in 2026?

FOXO Technologies Inc.'s Value Trap score is 53/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns FOXO Technologies Inc. (FOXO) a Quality of Company score of 3.9/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/FOXO/ · Methodology
Primary sources for this FOXO valuation
  • Financial statements: FOXO Technologies Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001812360) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for FOXO as of ; valuations recomputed .